ã¸ã§ãã¦ãã¤ãããåèã®MFå°æç¥ä»ããå¤å·£ã¨ã®å¯¾æ¦ãæ¯ãè¿ã£ãã 11æ¥ã第26åã¡ã°ããã«ããããã¯ãé»åã¢ãªã¼ãã§è¡ãããã¸ã§ãã¦ãã¤ãããåèã¨æã¬ã¤ã½ã«ã対æ¦ã0-1ã§æãåå©ããã ã·ã¼ãºã³éå¹ã1é±éå¾ã«æ§ããä¸ãæ¯å¹´æä¾ã¨ãªã£ã¦ããåèãã¼ãã¼ãæ¨å¹´ã¯æ°åã³ããã¦ã¤ã«ã¹(COVID-19)ã®å½±é¿ã§ä¸æ¢ã¨ãªã£ã¦ããã2å¹´ã¶ãã®éå¬ã¨ãªã£ãã å°æã¯ã2021å¹´ã«æããåèã¸ã¨å å
¥ãæ¨å¹´ã¯ä¸æ¢ã¨ãªã£ã¦ãããããæã¨å¯¾æ¦ããã®ã¯ä»åãåãã¦ãä¸é¨çµç¹ããè²ã£ãå¤å·£ã¨ã®å¯¾æ¦ã«ã¤ãã¦ã¯ãè² ãã¦ãã¾ã£ãã®ã§æããæ°æã¡ã§ãã£ã±ãã§ããã¨ã³ã¡ã³ãã試åã«è¨ãå¿å¢ã«ã¤ãã¦ã¯ããä¸è©±ã«ãªã£ãã¯ã©ãã§ãããã®ã§ãè² ãããã¯ãªãã£ãã§ãããåã¡ããã£ãã§ããçµæã¨ãã¦è² ãã¦ãã¾ã£ãã®ã§åãæããã§ããã¨ãæããã滲ã¾ããã 試åã«ã¤ãã¦ã¯ãè¯ãå ´é¢ãä½ã·ã¼ã³ãããã¾ãããã課é¡ããã®ä¸ã«ããã¾ã
{{#tags}}- {{label}}
{{/tags}}